Dynatronics - DYNT Company Value to Revenue Ratio

Public company logo of Dynatronics Corp. (DYNT)

The rehabilitation equipment market is highly fragmented, forcing Dynatronics Corporation (DYNT) to compete for clinic orders through its services. This EV/Sales chart provided by GURU.Markets visualizes asset demand, where shows the current value of the metric. Transparent management and a corporate focus on costs attempt to mitigate liquidity risks driven by chronic losses and intense pressure from distributors.

DYNT Dynatronics: EV/Sales Multiple in the range 07/04/2022 - 11/20/2026

DYNT (dynatronics.com): analytical breakdowns and indicator data

Fundamental valuation:Dynatronics Corp DYNT
Mass-produced product of Dynatronics Corporation

Market expectations for Dynatronics Corporation (DYNT) often clash with its limited operational scale and dependence on government budgets. By analyzing the company's valuation based on revenue excluding debt, an investor can observe the Enterprise Value to Revenue (EV/Revenue) ratio, which allows for an objective assessment of asset value regardless of leverage amidst high competition in the rehabilitation equipment sector.

Competitor analysis for Dynatronics Corporation

BSX (Boston Scientific) - Company Value to Revenue Ratio|EW: EV/Sales Multiple|RMD - Total Company Value-to-Revenue Ratio|PODD (Insulet Inc.) - EV/Sales Multiple|Company Value to Revenue Zimmer Biomet Corp (ZBH)|EV/Sales Multiple COO|Company Value to Revenue Align Technology, Inc. ALGN|EV/Sales Multiple GMED (globusmedical.com)|EV/Sales Multiple TransMedics Group, Inc. TMDX|ATEC - Enterprise Value-to-Revenue Ratio|AORT: Enterprise Value-to-Revenue Ratio|ENOV (Enovis Corporation) - Company Value to Revenue|Integra LifeSciences - Business Value to Revenue|ESTA (Establishment Labs Inc) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple Beta Bionics, Inc. BBNX|Enterprise Value-to-Revenue Ratio IRADIMED Corp (IRMD)|Embecta Corp. (EMBC) - Enterprise Value-to-Sales Ratio|Tandem Corp - Company Value to Revenue|EV/Sales Multiple AxoGen, Inc. AXGN|SI-BONE Inc - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Orthofix Medical OFIX|Bioventus Global (BVS) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume KIDS (OrthoPediatrics Inc.)|Enterprise Value-to-Revenue Ratio treace.com|Company Value to Revenue Strata Critical Medical Inc (SRTA)|EV/Sales Multiple CARL|RXST - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio clearpointneuro.com CLPT|STXS: Company Value to Revenue Ratio|STIM: Company Value to Revenue|sightsciences.com - Enterprise Value-to-Revenue Coefficient|Orchestra BioMed Inc. (OBIO) - Enterprise Value-to-Revenue Ratio|Anika (ANIK) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio InspireMD, Inc.|zhjmedical.com (ZJYL) - Total Company Value-to-Revenue Ratio|Company Value to Revenue VANI (Vivani Medical)|EV/Sales Multiple Xtant Medical Holdings, Inc. (XTNT)|Enterprise Value-to-Revenue Ratio NeuroOne Medical Technologies Corporation NMTC|EV/Sales Multiple Modular Medical MODD|MYO: Company Value to Revenue|Enterprise Value-to-Revenue Multiple Envoy Medical, Inc.|VVOS (Vivos Therapeutics) - Company Value to Revenue|Company Value to Revenue Ratio NVNO|Company Value to Revenue SINT|Company Value to Revenue Tenon Medical (TNON)|Enterprise Value-to-Revenue Ratio ReWalk Robotics Ltd (LFWD)|Total Company Value-to-Revenue Ratio Autonomix|EV/Sales Multiple IVF (invobioscience.com)|bonebiologics.com - Enterprise Value-to-Revenue Ratio|AXNX - Enterprise Value-to-Revenue Ratio|BIOL (BIOLASE) - Company Value to Revenue Ratio|Paragon 28, Inc. (FNA) - Enterprise Value-to-Revenue Ratio|INVO - Total Company Value-to-Revenue Ratio